Volitionrx (VNRX) Enterprise Value (2019 - 2025)
Volitionrx (VNRX) has disclosed Enterprise Value for 8 consecutive years, with -$1.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 76.89% year-over-year to -$1.5 million, compared with a TTM value of -$1.5 million through Sep 2025, up 76.89%, and an annual FY2024 reading of -$4.5 million, up 79.37% over the prior year.
- Enterprise Value was -$1.5 million for Q3 2025 at Volitionrx, up from -$3.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.5 million in Q3 2025 and bottomed at -$33.1 million in Q1 2021.
- Average Enterprise Value over 5 years is -$13.8 million, with a median of -$11.6 million recorded in 2023.
- The sharpest move saw Enterprise Value surged 92.84% in 2022, then tumbled 608.37% in 2023.
- Year by year, Enterprise Value stood at -$20.8 million in 2021, then skyrocketed by 45.11% to -$11.4 million in 2022, then tumbled by 89.51% to -$21.6 million in 2023, then skyrocketed by 79.37% to -$4.5 million in 2024, then skyrocketed by 66.09% to -$1.5 million in 2025.
- Business Quant data shows Enterprise Value for VNRX at -$1.5 million in Q3 2025, -$3.5 million in Q2 2025, and -$3.9 million in Q1 2025.